2006
DOI: 10.1097/00000542-200612000-00009
|View full text |Cite
|
Sign up to set email alerts
|

A Phase I, Two-center Study of the Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Children

Abstract: The pharmacokinetics of dexmedetomidine in children are predictable with a terminal half-life of 1.8 h. Hemodynamic responses decreased with increasing doses of dexmedetomidine. Respiratory responses were maintained, whereas sedation was transient.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

9
149
1
1

Year Published

2008
2008
2020
2020

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 202 publications
(160 citation statements)
references
References 20 publications
9
149
1
1
Order By: Relevance
“…Although uncommon, hypotension and bradycardia, when they do occur, appear to be dose-related, and a 30% decrease in BP and HR after a load of 1 mg/kg given over 10 minutes has been reported. 28,29 Other reported side effects include transient hypertension associated with a loading dose, nausea, and dry mouth. 30 Our experience with dexmedetomidine, knowledge of the pediatric data, and the fact that this patient represented a threat to both himself and the medical air transport team, led to the decision to sedate this severely agitated and combative child with dexmedetomidine for transport.…”
Section: Discussionmentioning
confidence: 99%
“…Although uncommon, hypotension and bradycardia, when they do occur, appear to be dose-related, and a 30% decrease in BP and HR after a load of 1 mg/kg given over 10 minutes has been reported. 28,29 Other reported side effects include transient hypertension associated with a loading dose, nausea, and dry mouth. 30 Our experience with dexmedetomidine, knowledge of the pediatric data, and the fact that this patient represented a threat to both himself and the medical air transport team, led to the decision to sedate this severely agitated and combative child with dexmedetomidine for transport.…”
Section: Discussionmentioning
confidence: 99%
“…3 Respiratory rate and hemoglobin oxygen saturation are unchanged after 1micro g/kg dexmedetomidine infused over 10 minutes Upper airway patency is maintained during dexmedetomidine sedation in children. 4 In a magnetic resonance imaging (MRI) study of healthy children who breathed spontaneously during dexmedetomidine (1 or 3 micro g/kg/h), the cross sectional areas of the nasopharynx and retroglossal space were only modestly reduced in comparison with baseline, and respiratory indices were maintained. 5 However, doses of 2 micro g/kg given as a bolus resulted in short episodes of apnoea.…”
Section: Respiratory Effectsmentioning
confidence: 99%
“…Pharmacokinetic models for dexmedetomidine in children have recently been produced from studies involving single bolus administration [44], after short infusions [45], and after longer infusions [46] for postoperative sedation. Further studies are needed to compare the predictive accuracy of these models to determine which perform optimally in clinically relevant situations.…”
Section: Pk Models For Dexmedetomidinementioning
confidence: 99%